Cargando…
Mechanistic modelling of enzyme‐restoration effects of new recombinant liver‐targeted proteins in acute intermittent porphyria
BACKGROUND AND PURPOSE: Acute intermittent porphyria (AIP) is a rare disease caused by a genetic mutation in the hepatic activity of the porphobilinogen‐deaminase. We aimed to develop a mechanistic model of the enzymatic restoration effects of a novel therapy based on the administration of different...
Autores principales: | Vera‐Yunca, Diego, Córdoba, Karol M., Parra‐Guillen, Zinnia P., Jericó, Daniel, Fontanellas, Antonio, Trocóniz, Iñaki F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310908/ https://www.ncbi.nlm.nih.gov/pubmed/35170015 http://dx.doi.org/10.1111/bph.15821 |
Ejemplares similares
-
Understanding Carbohydrate Metabolism and Insulin Resistance in Acute Intermittent Porphyria
por: Solares, Isabel, et al.
Publicado: (2022) -
Machine Learning Analysis of Individual Tumor Lesions in Four Metastatic Colorectal Cancer Clinical Studies: Linking Tumor Heterogeneity to Overall Survival
por: Vera-Yunca, Diego, et al.
Publicado: (2020) -
High Prevalence of Insulin Resistance in Asymptomatic Patients with Acute Intermittent Porphyria and Liver-Targeted Insulin as a Novel Therapeutic Approach
por: Solares, Isabel, et al.
Publicado: (2021) -
Acute intermittent porphyria, givosiran, and homocysteine
por: Fontanellas, Antonio, et al.
Publicado: (2021) -
Nutritional Interventions with Bacillus coagulans Improved Glucose Metabolism and Hyperinsulinemia in Mice with Acute Intermittent Porphyria
por: Longo, Miriam, et al.
Publicado: (2023)